Cloud-clone
SKU(재고 관리 코드):RPC285Hu01
Recombinant Anterior Gradient 2 (AGR2)
Recombinant Anterior Gradient 2 (AGR2)
Prokaryotic expression
Product No.
RPC285Hu01
Organism Species
Homo sapiens (Human).
Source
Prokaryotic expression
Host
E.coli
Endotoxin Level
<1.0EU per 1µg (determined by the LAL method)
Subcellular Location
Secreted, Endoplasmic reticulum lumen
Predicted Molecular Mass
21.5kDa
Accurate Molecular Mass
22kDa(Analysis of differences refer to the manual)
Residues & Tags
Arg21-Leu175 with N-terminal His Tag
Buffer Formulation
100mMNaHCO3, 500mMNaCl, pH8.3, containing 0.01% SKL, 5% Trehalose.
Traits
Freeze-dried powder
Purity
> 90%
Isoelectric Point
9.1
Applications
Positive Control; Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein.
UOM
10µg 50µg 200µg 1mg 5mg
SEQUENCE
USAGE
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Cancer Biomarkers | Serum AGR2 as an early diagnostic and postoperative prognostic biomarker of human lung adenocarcinoma MetaPress: n7137r6271u54118 |
| Molecular & Cellular Proteomics | Integrated Proteomic Profiling of Cell Line Conditioned Media and Pancreatic Juice for the Identification of Pancreatic Cancer Biomarkers PubMed: PMC3205865 |
| Prostate. | Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype Pubmed: 22911164 |
| BMC Cancer. | Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9 Pubmed: 24007603 |
| Clinical Cancer Research | Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer Pubmed:25239611 |
| PLoS One | AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection PubMed: 25875093 |
| Clinical Neurology and Neurosurgery | Serum AGR2 as a useful biomarker for pituitary adenomas S0303846717300045 |
| Oncotarget | Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2) Pubmed:29937991 |
| Int J Oncol | Anterior gradient protein 2 is a marker of tumor aggressiveness in breast cancer and favors chemotherapy‑induced senescence escape 34913074 |
| International Journal of Cancer | Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer Pubmed:35689436 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPC285Hu01 | Recombinant Anterior Gradient 2 (AGR2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC285Hu01 | Polyclonal Antibody to Anterior Gradient 2 (AGR2) | WB; IHC; ICC; IP. |
| LAC285Hu71 | Biotin-Linked Polyclonal Antibody to Anterior Gradient 2 (AGR2) | WB; IHC; ICC. |
| MAC285Hu21 | Monoclonal Antibody to Anterior Gradient 2 (AGR2) | WB; IHC; ICC; IP. |
| LAC285Hu72 | Biotin-Linked Monoclonal Antibody to Anterior Gradient 2 (AGR2) | WB; IHC; ICC. |
| SEC285Hu | ELISA Kit for Anterior Gradient 2 (AGR2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCC285Hu | CLIA Kit for Anterior Gradient 2 (AGR2) | Chemiluminescent immunoassay for Antigen Detection. |
| LMC285Hu | Magnetic Luminex Assay Kit for Anterior Gradient 2 (AGR2) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
